FAQ/Help |
Calendar |
Search |
Today's Posts |
09-01-2009, 09:24 PM | #1 | |||
|
||||
Senior Member
|
work on cognotropic pharmacology "...Scientists at the Bourdenko Institute of Neurosurgery in Moscow... have reported an array of specific drug effects. According to them, levodopa (L-dopa), a precursor of the neurotransmitter dopamine, improves the functions we typically associate with the posterior aspect of left frontal lobe: motor sequencing, speech initiation, and expressive language... By the same token, L-dopa seems to retard the functions commonly associated with the parietal lobes (spatial orientation and spatial construction). .."
http://www.sharpbrains.com/blog/2009...ecutive-brain/
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
Reply With Quote |
"Thanks for this!" says: | Sasha (09-02-2009) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
l-dopa and vitamin B | Parkinson's Disease | |||
Does L-dopa relieve PD tremor? | Parkinson's Disease | |||
Study: L-DOPA side effects can be blocked | Parkinson's Disease | |||
Serotonin 1B receptor agonists may block l-dopa side effects | Parkinson's Disease | |||
Does L-dopa (Sinemet) reduce tremor? | Parkinson's Disease |